Search results
Results from the WOW.Com Content Network
Hormone Imbalance and Weight Loss. Hormone-related health conditions, like polycystic ovary syndrome (PCOS) and hypothyroidism, as well as life seasons like menopause, can lead to hormonal changes ...
Some medical conditions disrupt metabolic processes, hampering your ability to lose weight in a caloric deficit, says Costa. "These include hypothyroidism , polycystic ovary syndrome, and insulin ...
Prednisone was patented in 1954 and approved for medical use in the United States in 1955. [3] [8] It is on the World Health Organization's List of Essential Medicines. [9] It is available as a generic medication. [3] In 2022, it was the 30th most commonly prescribed medication in the United States, with more than 18 million prescriptions. [10 ...
Corticosteroid-induced lipodystrophy (CIL) is a condition of abnormal fat deposition caused by corticosteroid medications. [1] Fat accumulates in the facial area ("moon face"), dorsocervical region ("buffalo hump"), and abdominal area ("pot belly" or "beer belly"), whereas the thickness of subcutaneous fat in the limbs is decreased. [1]
Moon face is often associated with Cushing's syndrome [5] [6] or steroid treatment (especially corticosteroids), which has led to it being known as Cushingoid facies. [7]Moon face is a type of corticosteroid-induced lipodystrophy along with "buffalo hump", which in one study occurred in 47% of the 820 patients.
Lower cortisol levels may reduce appetite and promote weight loss in some cases. But it could also lead to side effects like low blood sugar, fatigue, dizziness, cravings for salty comfort foods ...
Intentional weight loss is the loss of total body mass as a result of efforts to improve fitness and health, or to change appearance through slimming. Weight loss is the main treatment for obesity, [1] [2] [3] and there is substantial evidence this can prevent progression from prediabetes to type 2 diabetes with a 7–10% weight loss and manage cardiometabolic health for diabetic people with a ...
Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well Novo Nordisk's rival medicines Ozempic and Wegovy are being studied to see whether they can improve health ...